Comment on "Study on the association between Mettl3-modified Piezo1 in CD4+ T cells and inflammatory response in

Xia Qu1, Chunlian Li1, Dujiang Yang1

  • 1Department of orthopedics, The Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, NO.182, Chunhui Road, Longmatan District, Luzhou, Sichuan Province 646000, PR China.

Insights

The study on METTL3, Piezo1, and ankylosing spondylitis (AS) offers intriguing insights but requires further validation. Tissue-specific studies are needed to confirm the role of this pathway in AS pathogenesis and diagnosis.

Area of Science:

  • Immunology
  • Molecular Biology
  • Rheumatology

Background:

  • Ankylosing spondylitis (AS) pathogenesis involves complex immune responses.
  • The methyltransferase-like 3 (METTL3)-mediated m6A modification of Piezo1 in CD4+ T cells has been proposed in AS.
  • Current understanding relies on peripheral blood T cells, potentially missing tissue-specific mechanisms.

Purpose of the Study:

  • To critically evaluate the proposed role of METTL3-Piezo1 axis in ankylosing spondylitis (AS).
  • To assess the pathogenic and diagnostic implications of METTL3-mediated m6A modification of Piezo1 in CD4+ T cells.
  • To highlight the need for tissue-specific validation and mechanistic studies in AS.

Main Methods:

  • Review and critical analysis of existing data on METTL3, Piezo1, and CD4+ T cells in AS.
  • Comparison of peripheral blood findings with known enthesis and synovial pathobiology in AS.
  • Assessment of the limitations of bulk T-cell analysis and diagnostic performance metrics.

Main Results:

  • The study by Ren et al. suggests METTL3-mediated m6A modification of Piezo1 in CD4+ T cells.
  • Peripheral blood analysis may not fully represent AS pathobiology occurring at tissue sites.
  • The diagnostic utility of peripheral Piezo1 requires cautious interpretation due to potential confounding factors.

Conclusions:

  • The proposed METTL3-Piezo1 axis in AS requires further investigation with tissue-relevant models.
  • Mechanistic studies and functional rescue experiments are essential to confirm direct METTL3 regulation.
  • More rigorous validation is needed before this pathway can be established as pathogenic or a diagnostic biomarker in AS.